Meningeal cells and glia establish a permissive environment for axon regeneration after spinal cord injury in newts
© Zukor et al; licensee BioMed Central Ltd. 2011
Received: 10 September 2010
Accepted: 4 January 2011
Published: 4 January 2011
Newts have the remarkable ability to regenerate their spinal cords as adults. Their spinal cords regenerate with the regenerating tail after tail amputation, as well as after a gap-inducing spinal cord injury (SCI), such as a complete transection. While most studies on newt spinal cord regeneration have focused on events occurring after tail amputation, less attention has been given to events occurring after an SCI, a context that is more relevant to human SCI. Our goal was to use modern labeling and imaging techniques to observe axons regenerating across a complete transection injury and determine how cells and the extracellular matrix in the injury site might contribute to the regenerative process.
We identify stages of axon regeneration following a spinal cord transection and find that axon regrowth across the lesion appears to be enabled, in part, because meningeal cells and glia form a permissive environment for axon regeneration. Meningeal and endothelial cells regenerate into the lesion first and are associated with a loose extracellular matrix that allows axon growth cone migration. This matrix, paradoxically, consists of both permissive and inhibitory proteins. Axons grow into the injury site next and are closely associated with meningeal cells and glial processes extending from cell bodies surrounding the central canal. Later, ependymal tubes lined with glia extend into the lesion as well. Finally, the meningeal cells, axons, and glia move as a unit to close the gap in the spinal cord. After crossing the injury site, axons travel through white matter to reach synaptic targets, and though ascending axons regenerate, sensory axons do not appear to be among them. This entire regenerative process occurs even in the presence of an inflammatory response.
These data reveal, in detail, the cellular and extracellular events that occur during newt spinal cord regeneration after a transection injury and uncover an important role for meningeal and glial cells in facilitating axon regeneration. Given that these cell types interact to form inhibitory barriers in mammals, identifying the mechanisms underlying their permissive behaviors in the newt will provide new insights for improving spinal cord regeneration in mammals.
Unlike mammals, adult newts have the remarkable ability to recover function after they are paralyzed by a spinal cord injury (SCI). After a complete transection injury, newts regenerate their spinal cords and regain use of their hindlimbs in as little as 4 weeks  (Additional file 1). This recovery requires supraspinal axons to regenerate across the lesion and re-establish connections with downstream targets and is not simply due to a reorganization of circuits within the spinal cord . This finding led us to ask the question: why do axons regenerate across an injury site in the newt when they do not in mammals?
One of the main reasons why regeneration fails in mammals is because the environment of the injured spinal cord is inhibitory for axon regeneration . After an SCI, a variety of cell types, including astrocytes and meningeal fibroblasts, react in ways that prevent axons from regenerating across the injury site. These reactive cells create physical barriers to regeneration, such as a glial scar and a glia limitans at the border between the cord and the injury site. They also create an extracellular matrix (ECM) that is inhibitory or repulsive for axon growth cone migration.
Therefore, axon regeneration may be enabled in the newt, in part, because the environment of the injury site is not inhibitory. Cells may respond in ways that help rather than hinder axon regeneration such that physical barriers are not created and the ECM is not inhibitory.
Much of what is known about spinal cord regeneration in salamanders comes from studies of tail regeneration. After tail amputation, a blastema forms and ependymoglia (EG) lining the central canal of the spinal cord elongate an ependymal tube that precedes and serves as scaffold for axon regeneration . Regeneration in this context is thought to proceed as a recapitulation of developmental processes, and axons grow into newly developing tissues. Surprisingly, little is known about how axons regenerate after an SCI in the newt. In this context, axons must re-grow through an injury site having mature tissues on both sides of the lesion. This context is more relevant to the problem of spinal cord injury in humans. Older studies of SCI in the newt have noted that a blastema and glial scar do not appear to form , that axons can bridge large gaps in the cord before ependymal tubes elongate , and that, if left intact, the meninges can serve as a scaffold for axon regeneration . A more recent study of SCI in the axolotl, a neotenic larval salamander, found that EG appear to undergo an epithelial to mesenchymal transition, migrate into the injury site to form a solid mass, and then undergo a mesenchymal to epithelial transition to re-form an ependymal tube that serves as a scaffold for axon regeneration [7, 8]. In summary, previous studies suggest that physical barriers do not appear to form and EG and the meninges may help axons regenerate. Although O'Hara et al.  demonstrated that mesenchymal cells in the axolotl injury site were associated with fibronectin (FN), a permissive ECM protein, little else is known about the nature of the ECM of the injured newt spinal cord.
A focused and detailed study of axon regeneration and the cellular and extracellular environment axons encounter after an SCI in the newt has not been conducted. We, therefore, took advantage of modern labeling and imaging techniques to define, for the first time, stages of newt axon regeneration after a spinal cord transection injury and find that meningeal cells and glia, instead of interacting to form barriers to axon regeneration as they do in mammals [9, 10], appear to interact to form a permissive environment for axon regeneration in the newt. Our study examines many aspects of newt spinal cord regeneration, establishes the required foundation for further investigation into the cellular and molecular mechanisms controlling this naturally occurring process, and may inform new therapeutic approaches in regenerative medicine.
Results and discussion
The number of animals observed at each stage and time point
Spiking (no ET)
Spiking (with ET)
Growth beyond injury (not
Growth beyond injury
Spinal cord transection injury and axon tracer application
Stages of axon regeneration
Our tracer analyses uncovered six stages of axon regeneration that appeared to be typical and sequential (Figure 2). The timing for all but the first two stages was highly variable (Table 1). This variability is likely due to differences in the age, size, health and activity level of the animals as well as the size of the gap in the cord and not due to differences in the completeness of the transection injury. It was quite easy to completely transect the newt spinal cord and visually confirm that the transection was complete (Figure 1C). The adult newts used in this study were collected from the wild and their ages are unknown. As noted below, the size of the gap in the cord tended to increase before it decreased, perhaps because of body movements of the animal. The times in parentheses after each stage indicate the earliest and latest time points at which the stage was observed.
Retraction stage (1 day to 1 week, most often before 1 week)
Axons appear to have retracted away from the end of the cut cord (Figure 2A, B), and many axon tips have a balled-up morphology that is reminiscent of the dystrophic end-bulbs seen on axons that are unable to regenerate (Figure 2B") [13, 14]. Axon growth cones, however, can also be identified at this stage (Figure 2B').
Growth initiation stage (3 days to 2 weeks, most often at 1 week)
Axons appear to have initiated growth and grown back to the end of the cut cord (Figure 2C, D). As in the retraction stage, dystrophic axons and growth cones can be identified (Figure 2D', D"). The main difference between the first two stages is that many more axons extend to the end of the cut cord in the growth initiation stage. This difference is apparent even when all axons from the spinal cord are viewed in z-projections (Additional file 3). Also in this stage, the central canal, especially on the rostral side, begins to enlarge to form the terminal vesicle (TV).
Wrapping stage (2 weeks to 4 weeks)
Axons continue to grow and wrap around the end of the TV (Figure 2E, F). Residual numbers of dystrophic axons can still be seen at this and all subsequent stages. The meninges also wrap around, or bound, the end of the cord (Figure 2E, F) and often begin regenerating across the injury site ahead of the axons and TV (Figure 2F). The low density of cells within the injury site suggests that a scar is not forming. The size of the gap in the cord is also larger at this stage than at all other stages (Additional file 4). This could indicate that the wrapping stage is an abortive stage seen only in animals that do not recover function. We do not favor this interpretation, however, because wrapping axons are still evident at all subsequent stages, including the contact and growth beyond stage. This suggests that wrapping is a typical stage through which all regenerating spinal cords progress. The gap in the cord may get bigger before it gets smaller, simply as a result of body movements of the animal.
Wisping stage (2 weeks to 6 weeks)
Axons begin growing, or wisping, into the injury site ahead of the EG-lined TV (Figure 2G, H). Thus, as seen in previous studies of SCI in the newt, a pre-formed ependymal tube is not required for axon regeneration into the injury site [5, 6]. Wisping axons, however, do not grow into the ECM of the injury site alone but rather remain associated with cells. Many of these cells appear to be continuous with the meninges. At this stage, the meninges do not bound the end of the cord as they did in the wrapping stage but continue regenerating across the injury site, preceding the regenerating axons. Some wisping axons even appear to follow the regenerating meninges (Additional file 5).
Spiking stage (3 weeks to 6 weeks)
As wisping axons continue to grow, they may fasciculate to form a spike (Figure 2I, J; Additional files 6 and 7). Spiking axons are still associated with cells in the injury site and cells that are continuous with the meninges. Some spikes do not contain an ependymal tube (Figure 2J), while others do (Figure 2I). In spikes with an ependymal tube, the ependymal tube appears to have elongated from the end of the cut cord because the largest part of the TV and residual wrapping axons are seen well behind the tip of the spike (Figure 2I; Additional file 7). It is conceivable that a spike may not need to form. For example, if the gap in the cord is not large, wisping axons may be able to grow through the lesion and enter the cord on the opposite side without forming a spike.
Contact and growth beyond the injury site stage (3 weeks to 9 weeks)
In this stage, the two ends of the cord make contact with each other, and axons begin growing through the cord on the opposite side of the injury to re-establish functional connections (Figure 2K, L). All animals that had recovered swimming ability were in this stage, although not all animals in this stage had recovered function. Also, in all animals that had recovered, the ependymal tubes on each side of the injury had fused together to re-establish a continuous central canal. It was not possible to correlate the distance axons had regenerated beyond the injury site with functional recovery in this study because the axon tracer appears to fade out after 3 to 4 mm (Figure 2K, L). This is true even in the intact spinal cord (data not shown). There is some tolerance for sloppiness in how axons regenerate, for even in animals that had recovered function, wrapping axons were still evident (Additional files 8A and 9), some axons appeared to decussate (Additional files 8A' and 9), and separate fiber tracts could be seen traveling along the meninges (Figure 2K). It would be interesting to determine whether these aberrant axon trajectories are pruned or refined over time in animals that have been allowed to regenerate for longer than 9 weeks. Excessive sloppiness or gross misalignments may be the cause of a delay in or a complete failure of functional recovery (Additional files 8B-F and 10).
Sensory axons do not appear to regenerate
Tracer application to the sciatic nerve effectively labels, on the ipsilateral side only, sensory neurons in the spinal ganglia, motor neurons, dorsal column axons, and occasionally axons in a ventral location, which are presumably motor neuron axons exiting the cord to form the ventral root (Figure 3B). Labeled sensory and motor neurons were found mostly at the level of S1 and T-1 and occasionally at T-2 (Figure 3A).
To determine if sensory axons are among axons wisping into the injury site, 3-week regenerates received tracer application to the sciatic nerve 4 days prior to tissue harvest (n = 3). The spinal cord caudal to the injury site (T-2 to S1) was analyzed in cross-section to determine the effectiveness of the tracer application. Sensory and motor neurons and dorsal column axons were labeled in all three animals (Figure 3C). The injury site was analyzed in longitudinal sections to best view wisping axons. In sections through the dorsal columns, tracer-labeled sensory axons could be seen all the way up to the end of the cut cord (n = 2 out of 3; Figure 3D). In ventral sections through the region of wisping axons, however, none of the wisping axons were labeled with the tracer (Figure 3E).
To determine if sensory axons grow through and beyond an injury site, 6-week regenerates received rhodamine dextran amine (RDA) application to the sciatic nerve 4 days prior to tissue harvest. BDA was also used to label descending axons. The spinal cord caudal to the lesion and the lesion itself were analyzed in cross-section (n = 4). Sensory and motor neurons and dorsal column axons were effectively labeled with RDA in the spinal cord caudal to the lesion in three out of the four animals (Figure 3F). Two of the animals in which RDA was effectively applied had recovered function, and BDA-labeled descending axons could be seen growing through and at least 500 μm caudal to the injury site (Figure 3G, H). Despite this, RDA labeling in dorsal column axons got progressively weaker towards the injury, and RDA-labeled dorsal column axons were never seen in the injury site in any animal (Figure 3G, H).
We were not able to detect tracer-labeled sensory axons wisping into the lesion and growing through or beyond the lesion. This could indicate that sensory axons are either delayed or not regenerating or that the tracer faded out before the injury site. The tracer appears to travel a sufficient distance in four days to label wisping axons because it was seen robustly in dorsal column axons all the way up to the injury site in 3-week regenerates (Figure 3D). If the axons had regenerated, however, it is possible that the tracer was not detected in the injury site because of a dilution effect. The most likely explanation for why the tracer faded in the dorsal columns of the 6-week regenerates is because the dorsal column axons were degenerating . Therefore, sensory information may not be needed for functional recovery in the newt, or sensory information may be transmitted to the brain via a relay circuit that is formed by ascending propriospinal axons that do regenerate across the injury site.
Axons regenerate through white matter to reach functional targets
Axons regenerating beyond the injury site in zebrafish travel preferentially through the grey matter rather than white matter to reach functional targets . Our initial study of axon regeneration in whole-mount preparations suggested that this is not true in newts (Figure 2K, L). To investigate this further, descending axons in three 6-week regenerates in the growth beyond the injury site stage were analyzed in cross-section about 500 μm caudal to the injury site. All axons in all three animals traveled in the white matter only (Figure 3G). Thus, axons do not re-route through the grey matter to reach functional targets in the newt. This suggests that white matter inhibitors  either are not present in the newt spinal cord during axon regeneration or that newt axon regrowth is not inhibited by these molecules.
Extracellular matrix of the injured newt spinal cord
The ECM associated with an SCI in mammals is inhibitory or repulsive for axon growth cone migration . Chondroitin sulfate proteoglycans (CSPGs) are a major component of this inhibitory ECM. After injury, they are expressed by a variety of cell types, including astrocytes and meningeal cells, and they are expressed in the glial scar and glia limitans that forms at the border between the injury site and the spinal cord. They are also upregulated in the spinal cord itself in a gradient that increases as axons approach the injury site [18, 19]. ECM proteins that are canonically permissive for growth cone migration, such as FN [10, 20], laminin (LM)  and collagen (Col) , as well as ECM proteins with more ambiguous effects, such as tenascin C (TN-C) , are also expressed. Overall, however, the ECM is dense and does not support growth cone motility [23, 24].
Axon regeneration in the newt, then, may be enabled, in part, because the ECM of the injured newt spinal cord is not inhibitory. Consistent with previous studies, our initial axon regeneration experiments suggest that a dense scar does not form in the lesion (Figure 2E-J). To confirm this observation and determine if the ECM in the newt contains permissive rather than inhibitory proteins, we used immunohistofluorescence to analyze the expression of CSPGs, TN-C, FN, LM, and Col in wisping and spiking stage regenerates, the stages in which axons grow across the injury site. We used 2.5- to 3-week regenerates to target these stages (Additional file 11), and axons were labeled either with the axon tracer or an antibody against neurofilament associated protein (3A10).
Unlike CSPGs, TN-C, FN, Col, and LM are expressed in the intact cord in association with the meninges and blood vessels (Figure 4E, I, M, Q). After injury all of these proteins are expressed in a pattern similar to CSPGs. They are associated with the meninges and blood vessels (Figure 4F, G, J, K, N, O, R, S) and are expressed near wisping axons (Figure 4F, H, J, L, N, P, R, T). These proteins are not found in the grey or white matter of the injured spinal cord, do not form a barrier between the cord and injury site, and do not form a dense scar within the injury site. We occasionally detected a weak TN-C signal within the white matter of the spinal cord, but this signal was not significantly above background noise (autofluorescence and non-specific staining). A previous study detected a stronger TN-C signal in the white matter of the intact and regenerating newt tail spinal cord . We were unable to reproduce these results, perhaps because we were analyzing a different region of the spinal cord, a different regenerative context, or TN-C expression with different TN-C antibodies.
In summary, similar inhibitory and permissive ECM proteins are expressed in the injured newt and mammalian spinal cords, but the pattern of expression is different. In the newt, the ECM associated with wisping axons is loose and open, and a dense scar does not form. Also, ECM proteins are not present within the grey or white matter of the spinal cord, and the ECM does not form a permanent barrier, or glia limitans, between the cord and the injury site, though we do have preliminary evidence that such a barrier may exist transiently during the wrapping stage (Additional file 12). Overall, even though inhibitory CSPGs are expressed, the ECM of the injured newt spinal cord does appear to be more permissive for axon growth cone migration than that of the injured mammalian spinal cord.
Meningeal and endothelial cells are associated with wisping axons
To determine if cells associated with wisping axons and ECM are endothelial cells, we used the endothelial cell marker von Willebrand Factor (vWF), which appears to specifically label blood vessels in the newt spinal cord (Figure 5A). In wisping stage regenerates, vWF+ cells can be found in the injury site and near (Figure 5B, B") and ahead of (not shown) regenerating axons. These cells are also associated with FN, though not all of the FN is associated with vWF+ cells (Figure 5B, B', B"). It has been hypothesized that blood vessels and nerves, because of their close proximity and parallel tracts, guide each other during development . To determine whether they might guide one another during newt spinal cord regeneration, we analyzed injury sites in cross-sections. We found that though vWF+ cells and axons are in the injury site at the same time, they do not need to be in direct contact with each other (Figure 5C). Therefore, regenerating blood vessels and axons do not appear to guide one another across the injury site, at least not through a contact-mediated mechanism.
Many cells in the injury site were not vWF+, and much of the FN was not associated with vWF+ cells. We, therefore, sought to determine, more conclusively, if any of the cells closely associated with wisping axons and ECM were meningeal cells. Meningeal cell markers such as retinaldehyde dehydrogenase 2 (RALDH2) and NG2  did not produce a signal in our preparations (Additional file 13) so we used electron microscopy (EM) to analyze cell types based on ultrastructure. In the intact and regenerating spinal cords, meningeal cells, in general, have an electron-dense cytoplasm filled with mitochondria, an elongated nucleus with some clumped chromatin, and thin dark processes that are often associated with ECM (Figure 5E, F; Additional file 14). None of the other cell types in the intact cord shared these characteristics of meningeal cells (compare Additional files 14 and 15). In regenerating spinal cords, we observed cells with meningeal cell characteristics closely associated with regrowing axons. Figure 5H shows an enlargement of one of these cells. It has an electron dense cytoplasm filled with mitochondria, an elongated nucleus with some clumped chromatin, and thin dark processes that appear to wrap around a bundle of axons that has been cut in cross-section. Processes from this cell are also associated with ECM (Figure 5I). Another meningeal-like cell (Figure 5G) was associated with dura mater-like elements, namely ECM and fine, dark cell processes (Additional file 14B). Processes from the cell in Figure 5G form a closed loop, which suggests they may be attempting to wrap or cup around structures in their environment.
It is difficult to know with certainty the identity of the meningeal-like cells. Stensaas  suggested that cells with these characteristics were dark astrocytes derived from EG. Morphologically, however, these cells and their processes resemble meningeal cells far more than they do EG and astrocytes (Additional files 15 and 16). Although these cells appear to wrap around axons, we and Stensaas  saw no evidence of them forming myelin, and therefore we do not think they are oligodendrocytes or Schwann cells. Further support for the idea that these cells may be meningeal cells comes from studies of meningeal cells that are transplanted into injured mammalian spinal cords along with olfactory ensheathing cells (OECs). Such meningeal cells appear to wrap axons into fascicles much like fibroblasts in the perineurium of peripheral nerves wrap axons [28, 29]. These meningeal cells were also associated with ECM and had morphological features similar to our meningeal-like cells.
Ependymoglial and astrocytic processes are associated with wisping axons
In the injured spinal cord, GFAP expression is maintained in astrocytes and EG around the central canal. It does not appear to be upregulated, and GFAP+ processes do not appear to be thicker than they are in the intact cord (compare Figure 6A and 6B). Therefore, astrocytes do not appear to become hypertrophic. In the injury site, only a few GFAP+ cell bodies can be found (Figure 6D, D'). These cells are more likely to be EG than astrocytes because they express GFAP only weakly. Thus, astrocytes do not migrate into the lesion. In wisping stage regenerates, GFAP+ processes are closely associated with wisping axons (Figure 6D, D'). These processes likely originate from EG and astrocytes that surround the central canal. Rather than being aligned perpendicular to axons, as they are during tail regeneration, however, the GFAP+ processes are aligned more parallel to the direction in which axons travel. This is especially evident in later-stage regenerates (Figure 6E). Note also that the GFAP+ processes do not form a glia limitans between the cord and the injury site as they do in mammals (Figure 6B, D).
These data demonstrate that, while the EG response after SCI appears to be different to that after tail amputation, EG are still likely to be playing an important role in enabling axon regeneration because GFAP+ processes are closely associated with axons growing across the injury site. Also, while EG do not appear to migrate into the injury site in large numbers, there are a few that appear to do so.
Furthermore, the astrocytic response in the newt is very much different to that seen in mammals. Newt astrocytes do not appear to become hypertrophic, migrate into the injury site, express ECM, or form a glia limitans or scar. Instead of inhibiting axon regeneration as they do in mammals, newt astrocytes may, like EG, play a supportive role because many of the GFAP+ processes associated with axons likely arise from astrocytes as well as EG.
An inflammatory response is present but does not appear to be detrimental to regeneration
It has been hypothesized that inflammation leads to scarring and non-regenerative wound healing and that it is not present in systems that regenerate . In support of this, macrophages in the injured mammalian spinal cord contribute to the formation of the scar  and have even been shown to physically interact with axons to cause retraction .
To confirm the presence of various types of inflammatory cells, we again tried several cell-type specific antibodies, but these did not produce a reliable signal in our preparations (Additional file 13). We were, however, able to identify many phagocytic cells, or functional macrophages, in the region of regenerating axons in our EM images. Asterisks in Figures 5E and 7C mark obvious macrophages. These macrophages could even be seen to be in direct contact with axons (Figure 7D). Figure 7E shows another example of a meningeal-like cell process that is closely associated with regenerating axons as well as ECM.
These data demonstrate that an inflammatory response does appear to be present in the injured newt spinal cord, but does not appear to be detrimental to the regenerative response. In fact, one of the most severe cases of inflammation was seen in a contact stage regenerate (Additional file 17C,C'). The inflammation, which was likely present at earlier stages as well, did not prevent regeneration from progressing to this advanced stage. The interaction of newt macrophages with axons, if it also causes axon retraction in newts, does not prevent the net response to be that of axon growth. Perhaps the beneficial effects the immune system can have on regeneration  outweigh any detrimental effects in the newt.
Based on our observations, we propose a glia-meningeal cell interaction model of spinal cord regeneration: spinal cord regeneration is enabled when meningeal cells and glia (astrocytes and EG) interact to form a conduit for axon regeneration rather than an inhibitory barrier (scar, glia limitans, and dense ECM). Simpson  hypothesized that successful spinal cord regeneration depends upon an interaction between mesenchymal cells and the ependymal epithelium that stimulates the ependyma to proliferate and form a scaffold, which guides axons across the lesion. Since astrocytes also appear to be an important component in this interaction, we have included astrocytes with the ependymal cells and refer to them as glia. Simpson postulated that blastemal cells are the important mesenchymal cell after tail amputation, but was not specific about which cells play that role after SCI. We suggest that meningeal cells are an important mesenchymal cell after SCI and that they, too, can provide a scaffold for axon growth and guidance.
Our model of spinal cord regeneration after an SCI is similar to that after tail amputation in that EG play a central role. Their processes are closely associated with regenerating axons and may provide a substratum for growth cone migration and guidance via cell-cell adhesion. Our data also suggest that astrocytes may play a similar role. These astrocytes may be immediate descendants of EG and not the fully mature astrocytes seen in the mammalian spinal cord , and this may explain, in part, why they respond so differently to SCI. The arrangement of the glial processes, however, is different from the tail regeneration model, at least initially. Instead of extending radially from a pre-formed ependymal tube to form channels through which axons can grow , they extend longitudinally ahead of the TV and run roughly parallel to the regenerating axons. Such glial support may allow the axons to grow into the injury site in the absence of a pre-formed tube. They may also help guide the EG lining the central canal, and thus the ependymal tube, into the region of wisping axons, similar to the way in which radial processes guide newborn neurons to their proper locations in the developing cortex. Soma may translocate as their processes shorten, or they may migrate along the processes of other EG . Given that very few cells in the injury site express GFAP, we do not think many EG undergo an epithelial to mesenchymal transition to migrate freely into the lesion as proposed for axolotls after SCI . This does not rule out the possibility, however, that undifferentiated progeny of EG might migrate into the injury site. Alternatively, given that the mesenchymal cells in the axolotl injury site were also GFAP- and were associated with FN, such cells could be meningeal and/or endothelial cells.
Unlike most previous models of salamander spinal cord regeneration, our model assigns an important role to meningeal cells. Although they are thought to be detrimental to axon regeneration in the injured mammalian spinal cord, meningeal cells are able to stimulate, support, and guide developmental and regenerative processes in other contexts. Meningeal cells are fibroblast-like, and fibroblasts in flesh wounds are responsible for remodeling the ECM into either scar or normal tissue. The difference appears to depend on whether the fibroblasts are stimulated by transforming growth factor (TGF)β1 or TGFβ3 . As mentioned previously, meningeal cells harvested from the olfactory bulb, a part of the nervous system that does regenerate, and transplanted into a mammalian SCI along with OECs appear to fasciculate axons into perineurial-like structures and enhance the ability of OECs to remyelinate axons [28, 29]. During development, the meninges serve as substratum for and secrete a chemoattractant, CXCL12, which regulates the migration of Cajal-Retzius cells . In the developing forebrain, the meninges secrete retinoic acid, which stimulates radial glia to begin producing neurons . Meningeal cells in mammalian SCI express retinoic acid and permissive ECM proteins, such as LM and FN [27, 40]. Retinoic acid has been shown to stimulate and possibly be an attractant for neurite outgrowth [41, 42]. While the permissive ECM proteins expressed by meningeal cells in vitro tend to form a basal lamina that axons cannot cross, axons appear to grow quite well along it . Thus, the basal lamina can either guide or inhibit axon regeneration depending on its orientation. In fact, following a large ablation of the spinal cord in which the meninges were left intact, axons were seen regenerating along the basal lamina of the meninges, which was oriented in a productive direction parallel to axon regrowth .
Our model does not exclude the possibility that axons and axon intrinsic properties also play an important role in newt spinal cord regeneration. The 1 week required for growth initiation suggests that an intrinsic growth potential is activated. This is supported by the fact that a 1-week conditioning lesion encouraged neurite outgrowth from newt retinal explants . Activation of intrinsic growth could also enable axons to overcome any inhibition CSPGs might inflict, similar to the way in which embryonic neurons adapt to CSPGs [44, 45]. Furthermore, matrix metalloproteinases are upregulated during newt spinal cord regeneration (unpublished observations), and if they are expressed in growth cones, they could breakdown inhibitory ECM molecules and allow the axons to grow through regions that would normally be non-permissive. Axons may also directly influence the behavior of the cells in their environment. Nerves are required for newt limb regeneration, and they stimulate Schwann cells to produce anterior gradient protein, a factor that is sufficient to rescue regeneration in de-nervated limbs . Regenerating optic nerve axons in the frog appear to stimulate a breakdown of the blood brain barrier at the front of regenerating axons . Finally, when degenerated optic nerve fragments containing hypertrophic astrocytes are implanted into an optic nerve injury site in frogs, axons grow into the grafted tissue and appear to stimulate the reactive astrocytes to adopt a more permissive architecture: the astrocytes extend radial processes and form compartments for axon elongation . Thus, newt axons may play a role in stimulating appropriate glial and meningeal cell responses.
If meningeal cells and glia support the development and regeneration of the nervous system in some contexts, why do they not do so in all contexts? Although no definitive answer can be put forward, we suspect that the state of differentiation of the cells may play a key role. In the newt spinal cord, EG maintain characteristics of radial glia of the developing cortex , astrocytes may be recent progeny of EG , and many differentiated cells have the ability to dedifferentiate and become more progenitor-like . An exciting new study in mouse suggests that mammalian glia, and possibly mammalian meningeal cells, may retain the capacity to respond to an SCI in ways that support axon regeneration. When the tumor suppressor gene PTEN (phosphatase and tensin homolog) is deleted in mouse corticospinal neurons, the neurons are able to regenerate axons across an SCI, and their axons cross the injury site in close association with GFAP+ cells and cell processes . These GFAP+ bridges tended to appear around the edges of the spinal cord, the regions that are closest to the meninges. Learning more about how newt cell types are intrinsically different from their mammalian counterparts and what factors stimulate newt cell types to respond and interact in ways that promote axon regeneration may help us develop methods to cultivate similar behaviors in mammalian cells. Identifying effective treatments for spinal cord injury in mammals has been so intractable that it is imperative we take full advantage of the opportunity to learn how nature has already solved this problem in newts.
Materials and methods
Adult newts, N. viridescens, were purchased from Charles D Sullivan Co. Inc. (Nashville, TN, USA), housed at 22°C in glass aquariums equipped with water filters, and fed live blackworms, Lumbriculus varietgatus (Eastern Aquatics, Lancaster, PA, USA). All animal protocols were approved by the University of Utah Institutional Animal Care and Use Committee.
Spinal cord injury
Newts were anesthetized by submersion in 0.1% Tricaine (ethyl 3-aminobenzoate methanesulfonate salt; Sigma, St. Louis, MO, USA) in 20 mM Tris-HCl, pH 7.5 for 10 minutes and placed in ice for 30 minutes prior to surgery. Complete transection injuries were performed similar to those described in Davis et al. [1, 12]. After swabbing the skin with 10% providone iodine, a deep incision was made between vertebral bones about 1 cm rostral to the hindlimbs. Using forceps, the vertebrae were gently and slightly separated and the dorsal lamina of the caudal vertebra was removed to expose the spinal cord. The spinal cord was cut completely with fine spring scissors. The completeness of the transection was easily verified by visual inspection (Figure 1C). Blood was irrigated with sterile 85% PBS when necessary. Animals were kept moist during the procedure, placed on ice for 15 minutes after the surgery, and allowed to recover in bins that were tilted to produce a shallow area of water. Bins were cleaned and filled with fresh de-chlorinated water every day or every other day throughout the recovery period.
Axon tracer application
Our procedure was modified from that used in zebrafish [15, 16]. Three axon tracers were tried: BDA (3 kDa, lysine fixable, Invitrogen, Carlsbad, CA, USA, D7135), RDA (3 kDa, lysine fixable, Invitrogen, D3308), and biocytin (Pierce, Rockford, IL, USA, #28022). RDA appeared to work as well as BDA, but was only used when two tracers were needed in the same animal. Biocytin, which was reported to reveal thin processes better than a 10 kDa RDA , unfortunately did not produce a signal in our preparations, perhaps because of the decalcification step in tissue processing (see below). BDA and RDA were prepared similarly: small pieces of gel foam (Pharmacia and Upjohn Co., Kalamazoo, MI, USA) were soaked in 1.5 μl of a 10% solution and allowed to air dry 40 minutes in a tissue culture hood to further concentrate the solution. Fast green dye (Fisher, Waltham, MA, USA, F-99) was added to the BDA solution at 0.05 mg/ml to make it visible in vivo. Biocytin did not readily go into solution at 10%, but a slurry was made. Small pieces of gel foam were soaked in 10 μl of the slurry, air dried completely, and stored at -20°C. To apply tracer to the spinal cord, the cord was transected one vertebral segment (about 2 mm) rostral or caudal to the original injury site using the same procedure described above and a piece of gel foam saturated with tracer was inserted into the gap. To apply tracer to the sciatic nerve, an incision was made along the course of the sciatic blood vessel on the posterior aspect of the hindlimb where the hindlimb joins with the body. Fine forceps were used to tease the nerve from the vessel, and the nerve was transected with fine spring scissors. A piece of gel foam saturated with tracer was applied and the wound was sealed closed with Vetbond tissue adhesive (3M, St. Paul, MN, USA). Excessive bleeding was controlled before tracer application, if necessary, by inserting a piece of gel foam into the wound and allowing the animal to sit on ice for several minutes. Use of this technique was minimized, however, because it decreased the efficiency of tracer uptake.
Tissue harvest, fixation, and decalcification
Animals were anesthetized as above, placed on ice for at least 15 minutes, then perfused with about 1.5 ml 85% PBS followed by 3 ml periodate-lysine-paraformaldehyde (PFA) fixative (PLP: 75 mM lysine, 10 mM sodium periodate, 0.5% PFA in 85% PBS, pH 7.4; 0.1 M lysine and 2% PFA stocks were stored at -20°C and ingredients were mixed and used within 2 hours) . All incubations were performed rocking at room temperature (RT) and rinses were for 20 to 30 minutes, three times, unless otherwise specified. The spinal column was harvested in about 4 mm long segments, post-fixed in PLP for 2 hours, rinsed with PBS (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.15 mM KH2PO4, pH 7.4), rinsed in fresh PBS overnight at 4°C, decalcified with Morse's solution (22.5% formic acid, 10% sodium citrate) for 24 hours, and rinsed with PBS. Some of the spinal cords prepared for paraffin sections were not perfusion fixed and this did not seem to affect the results, though perfusion did make tissue prepared for thick and frozen sections easier to section. An alternative fixative, 4% PFA, was tried, but the quality of sections was not improved, there was more autofluorescence, and some antibodies did not work as well.
Thick sections and fluorescent labeling (spinal cord whole-mounts)
Methods were adapted from previous studies [53, 54] and described in Zukor et al. . All incubations were performed rocking at RT unless otherwise specified. Decalcified tissue was bleached with formamide bleach (6% hydrogen peroxide, 3% formamide, 0.1% Triton X-100 in PBS) for about 2 hours; rinsed with PBS for 20 to 30 minutes, three times; and embedded in 4% agarose. Longitudinal sections containing the whole spinal cord (about 350 μm thick) were cut on a vibratome and collected in ice cold PBS. Sections were transferred to 0.67 ml centrifuge tubes, permeabilized with PBS-TxD (PBS containing 0.5 to 2% Triton X-100 and 20% DMSO; 0.5% Triton X-100 was sufficient for streptavidin, 2% was necessary for antibodies) overnight and incubated in streptavidin or primary antibody diluted in PBS-TxDB (PBS-TxD containing 1% BSA (EMD, Gibbstown, NJ, USA, #2960) and 0.1% fish skin gelatin (Sigma, G7765) as blocking reagents) for 7 days for streptavidin or 10 days for antibody penetration. Sections needing incubation with secondary antibodies were rinsed with PBS-Tx (PBS with 2% Triton X-100) for 30 minutes, five times and incubated in secondary antibody diluted in PBS-TxDB for 10 days. Sections were then rinsed in PBS for 30 minutes, four times; rinsed in TNT (100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween-20) for 30 minutes; incubated in SYTOX green (Invitrogen, S7020) diluted 1/1,000 in DMSO, then 1/25 in TNT for 3 hours to stain nuclei; and rinsed in TN (TNT without Tween-20) for 10 minutes, three times. Sections were transferred to glass vials, dehydrated through a methanol (MeOH)/TN series (20%, 50%, 75%, 100% MeOH; 15 minutes each); and cleared in BABB (1 part benzyl alcohol, 2 parts benzyl benzoate) overnight at 4°C (not rocking).
Frozen sections of the injured spinal cord were difficult to obtain presumably because it contains more water than the intact cord and because the spinal column contains tissues of heterogeneous density: the muscle and bone are rigid and dense, while the spinal cord is quite soft. Therefore, methods were adapted from Tokuyasu . Perfusion-fixed, decalcified tissue was cryoprotected to 2.3 M sucrose in PBS (3 hours in 25%, 3 hours in 50%, overnight in 75%, 24 hours in 100% 2.3 M sucrose; rocking and at RT) and frozen quickly in OCT (Ted Pella, Redding, CA, USA, #27050) with liquid nitrogen to minimize freezing artifacts. Sections 16 to 20 μm thick were obtained on a cryostat with the chamber temperature set to -35°C and the object temperature set to -34°C. For intact spinal cord, variables could be somewhat relaxed. Tissue could be cryoprotected to 1.6 M sucrose and perfusion was not critical. Sections were stored at -20°C and, prior to fluorescent labeling, thawed, baked onto the slides for 1 hour at 50°C, and rinsed in PBS for 5 minutes.
All incubations were performed with rocking at RT. Decalcified tissue was dehydrated with ethanol (EtOH; 50% for 30 minutes, 70% for 30 minutes, 95% for 30 minutes, 100% for 30 minutes, 100% for 1 hour), infiltrated (75% Hemo-De in EtOH for 20 minutes, 100% Hemo-De for 1 hour, paraffin for 1 hour at 60°C and 15 Hg vacuum), and embedded in paraffin. Sections 10 to 20 μm thick were mounted onto slides, left on a 37°C slide warmer overnight, and stored at 4°C. Prior to fluorescent labeling or staining, sections were dewaxed (Hemo-De for 10 minutes, 2 times; 75% Hemo-De in EtOH for 5 minutes; 100% EtOH briefly and then for 3 minutes) and rehydrated (95% EtOH for 3 minutes, 70% EtOH for 3 minutes, PBS or water for 5 minutes; PBS was used for fluorescent labeling and water was used for staining).
Paraffin sections rehydrated in water were stained: hematoxylin (Harris modified, with acetic acid; Fisher, Waltham, MA, USA, SH26-500D) 4 minutes, running tap water 5 minutes, 70% EtOH briefly, acidified 70% EtOH (10 drops of concentrated HCl to 200 ml 70% EtOH) 1.5 minutes, bluing solution (10 drops of NH4OH in 200 ml EtOH) 1 minute, Scott's solution (1 g sodium bicarbonate, 10 g magnesium sulfate in 500 ml water) 3 minutes, running tap water 5 minutes, 70% EtOH briefly, 0.1% Eosin in 95% EtOH (made from 0.5% Eosin Y Solution, Sigma HT110-1-32) 1 minute, 95% EtOH briefly, 100% EtOH 5 minutes, 75% Hemo-De in EtOH 5 minutes, 100% Hemo-De 5 minutes. Coverslips were mounted with Cytoseal 60 (Fisher, 23-244-256).
Fluorescent labeling in paraffin or frozen sections
Sections were blocked in PBS-TxB (PBS with 0.2% Triton X-100, 1% BSA and 0.1% fish skin gelatin) for 1 hour; incubated with primary antibody diluted in PBS-Tx (PBS with 0.2% Triton X-100) overnight at RT; rinsed with PBS for 10 minutes, three times; incubated with secondary antibody or streptavidin diluted in PBS-Tx for 4 hours; rinsed with PBS for 10 minutes, two times; rinsed with TNT or TN for 10 minutes; incubated with SYTOX green (Invitrogen, S7020) diluted 1/1,000 in DMSO, then 1/50 in TNT or Hoechst 33342 (Invitrogen, A10027) diluted 1/2,000 in TNT for 30 minutes to stain nuclei; rinsed in TN for 10 minutes, 50% TN for 10 minutes, and water for 10 minutes. Coverslips were mounted with Fluoromount G (Fisher, OB100-01) and sealed with clear nail polish. For some experiments on paraffin sections, incubation with primary antibody was extended to 2 or 3 days at RT. This improved signal without adding noise. Sections treated with chondroitinase ABC (chABC) were treated before the blocking step. They were equilibrated in tris acetate buffer (50 mM Tris-HCl, pH 8.5, 60 mM sodium acetate, 0.02% BSA, 0.5% Triton X-100; made fresh, pH 8.0) for 5 minutes, treated with chABC solution (7.5 U/ml chABC stock diluted 1:50 in tris acetate buffer; stock was chABC, Sigma C2905, EC 18.104.22.168, reconstituted in 0.01% BSA) for 1 hour at 37°C, and rinsed with PBS for 5 minutes, three times.
Antibodies and streptavidins
Table of antibodies
Company, catalogue number
Mouse IgM mAb
Sigma, C8035 (CS-56)
Mouse IgM mAb
Mouse IgG mAb
Collagen XII (newt)
Mouse IgG1 mAb
Mouse IgG1 mAb
Neurofilament associated protein (chick)
Mouse IgG1 mAb
von Willebrand factor (human)
Confocal imaging and image processing
Sections labeled with fluorescent dyes were imaged on an Olympus FV300 or FV1000 laser scanning confocal microscope using a 10× or 20× air objective. Images were processed with Image J, version 1.40 g  and Adobe Photoshop CS2. Levels were adjusted in Photoshop to maximize the signal to noise ratio but the same adjustments were made to experimental and control images.
Preparation of tissue for electron microscopy
Methods were adapted from Anderson et al. . Animals were anesthetized as above, then perfused with about 1.5 ml 85% PBS followed by 3 ml EM fixative (2.5% glutaraldehyde, 1% formaldehyde, 3% sucrose, 1 mM MgSO4 in 0.1 M cacodylate buffer (CB), pH 7.4). The spinal column was harvested in about 4 mm long segments; post-fixed in EM fixative overnight at RT; decalcified in cold EDTA solution (0.1 M EDTA, pH 7.2 to 7.4 with 4% glutaraldehyde) for 4 days at 4°C; rinsed in 0.1 M CB for 20 minutes, three times; rinsed in PBS briefly; and embedded in 4% agarose. Longitudinal sections containing the whole spinal cord (about 350 μm thick) were cut on a vibratome and collected in ice cold PBS. Sections were returned to 0.1 M CB; osmicated (1% OsO4 in 0.1 M CB) for 1 hour; rinsed in 0.1 M CB for 10 minutes, three times; partially dehydrated (50%, 75% MeOH; 10 minutes each); treated with 1% uranyl acetate in 75% MeOH for 1 hour; fully dehydrated (75%, 85%, 95%, 100%, 100% MeOH; 10 minutes each); infiltrated with resin (100% acetone 10 minutes, two times; 75% resin in acetone overnight; 100% resin 1 hour); embedded in epoxy resin (2 parts dodecenyl succinic anhydride (DDSA, Ted Pella, 18022), 1 part eponate 12 resin (Ted Pella, 18005), 0.06 parts DMP30 accelerator (Ted Pella, 18042)) and cured at 60°C for 2 days. Sections were re-embedded for longitudinal sectioning, and 80-nm sections were collected onto carbon-coated Formvar films in gold single-hole grids, stained with 5% uranyl acetate for 1 hour and 1% lead citrate for 25 minutes, and imaged at 80 KeV in a JEOL JEM 1400 electron microscope at 5,000× magnification. Images were captured digitally on a GATAN Ultrascan 4000 16 megapixel 16-bit camera and mosaicked with ir-tools . Mosaics were viewed and selections were captured with Viking software.
biotinylated dextran amine
bovine serum albumin
chondroitin sulfate proteoglycan
glial fibrillary acidic protein
hematoxylin and eosin
olfactory ensheathing cell
phosphate buffered saline
rhodamine dextran amine
spinal cord injury
von Willebrand factor.
We thank the following individuals for their valuable contributions to this study: Alejandro Sánchez Alvarado for a critical reading of the manuscript; Robert Marc, Bryan Jones, Felix Vasquez-Chona, Drew Ferrell, Jia-Hui Yang, Carl Watt, James Anderson for assistance with EM; Larry Stensaas for his expertise in interpreting the EM data; Chris Rodesch and the University of Utah Cell Imaging Core for help with confocal microscopy; Gerald Spangrude for his expertise with the analysis of the inflammatory response; and Namakkai and Vasanthi Rajasekaran for technical assistance with the western blots. Several antibodies were provided by the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242. This work was supported by a grant from the Craig H Neilsen Foundation to SJO. KAZ was supported by a NIH Developmental Biology Training Grant (5T32 HD07491). DTK was supported by a NIH Cardiology Fellowship Training Grant (5T32 HL07576).
- Davis BM, Ayers JL, Koran L, Carlson J, Anderson MC, Simpson SB: Time course of salamander spinal cord regeneration and recovery of swimming: HRP retrograde pathway tracing and kinematic analysis. Exp Neurol. 1990, 108: 198-213. 10.1016/0014-4886(90)90124-B.View ArticlePubMedGoogle Scholar
- Silver J, Miller JH: Regeneration beyond the glial scar. Nat Rev Neurosci. 2004, 5: 146-156. 10.1038/nrn1326.View ArticlePubMedGoogle Scholar
- Singer M, Nordlander RH, Egar M: Axonal guidance during embryogenesis and regeneration in the spinal cord of the newt: the blueprint hypothesis of neuronal pathway patterning. J Comp Neurol. 1979, 185: 1-21. 10.1002/cne.901850102.View ArticlePubMedGoogle Scholar
- Piatt J: Regeneration of the spinal cord in the salamander. J Exp Zool. 1955, 129: 177-207. 10.1002/jez.1401290109.View ArticleGoogle Scholar
- Butler EG, Ward MB: Reconstitution of the spinal cord after ablation in adult Triturus. Dev Biol. 1967, 15: 464-486. 10.1016/0012-1606(67)90038-3.View ArticlePubMedGoogle Scholar
- Stensaas LJ: Regeneration in the spinal cord of the newt Notopthalamus (Triturus) pyrrhogaster. Spinal Cord Reconstruction. Edited by: Kao CC, Bunge RP, Reier PJ. 1983, New York: Raven Press, 121-149.Google Scholar
- O'Hara CM, Egar MW, Chernoff EA: Reorganization of the ependyma during axolotl spinal cord regeneration: changes in intermediate filament and fibronectin expression. Dev Dyn. 1992, 193: 103-115.View ArticlePubMedGoogle Scholar
- Chernoff EA, Stocum DL, Nye HL, Cameron JA: Urodele spinal cord regeneration and related processes. Dev Dyn. 2003, 226: 295-307. 10.1002/dvdy.10240.View ArticlePubMedGoogle Scholar
- Shearer MC, Fawcett JW: The astrocyte/meningeal cell interface - a barrier to successful nerve regeneration?. Cell Tissue Res. 2001, 305: 267-273. 10.1007/s004410100384.View ArticlePubMedGoogle Scholar
- Bundesen LQ, Scheel TA, Bregman BS, Kromer LF: Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J Neurosci. 2003, 23: 7789-7800.PubMedGoogle Scholar
- Francis ETB: The Anatomy of the Salamander. 2002, Salt Lake City: Society for the Study of Amphibians and ReptilesGoogle Scholar
- Davis BM, Duffy MT, Simpson SB: Bulbospinal and intraspinal connections in normal and regenerated salamander spinal cord. Exp Neurol. 1989, 103: 41-51. 10.1016/0014-4886(89)90183-0.View ArticlePubMedGoogle Scholar
- Ramony Cajal S: Degeneration and Regeneration of the Nervous System. 1928, London: Oxford University PressGoogle Scholar
- Tom VJ, Steinmetz MP, Miller JH, Doller CM, Silver J: Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J Neurosci. 2004, 24: 6531-6539. 10.1523/JNEUROSCI.0994-04.2004.View ArticlePubMedGoogle Scholar
- Becker T, Wullimann MF, Becker CG, Bernhardt RR, Schachner M: Axonal regrowth after spinal cord transection in adult zebrafish. J Comp Neurol. 1997, 377: 577-595. 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#.View ArticlePubMedGoogle Scholar
- Becker T, Becker CG: Regenerating descending axons preferentially reroute to the gray matter in the presence of a general macrophage/microglial reaction caudal to a spinal transection in adult zebrafish. J Comp Neurol. 2001, 433: 131-147. 10.1002/cne.1131.View ArticlePubMedGoogle Scholar
- Xie F, Zheng B: White matter inhibitors in CNS axon regeneration failure. Exp Neurol. 2008, 209: 302-312. 10.1016/j.expneurol.2007.07.005.PubMed CentralView ArticlePubMedGoogle Scholar
- Tang X, Davies JE, Davies SJ: Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res. 2003, 71: 427-444. 10.1002/jnr.10523.View ArticlePubMedGoogle Scholar
- Davies SJ, Goucher DR, Doller C, Silver J: Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci. 1999, 19: 5810-5822.PubMedGoogle Scholar
- Herrmann JE, Shah RR, Chan AF, Zheng B: EphA4 deficient mice maintain astroglial-fibrotic scar formation after spinal cord injury. Exp Neurol. 2010, 223: 582-598. 10.1016/j.expneurol.2010.02.005.PubMed CentralView ArticlePubMedGoogle Scholar
- Busch SA, Horn KP, Cuascut FX, Hawthorne AL, Bai L, Miller RH, Silver J: Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J Neurosci. 2010, 30: 255-265. 10.1523/JNEUROSCI.3705-09.2010.PubMed CentralView ArticlePubMedGoogle Scholar
- Hermanns S, Reiprich P, Muller HW: A reliable method to reduce collagen scar formation in the lesioned rat spinal cord. J Neurosci Methods. 2001, 110: 141-146. 10.1016/S0165-0270(01)00427-7.View ArticlePubMedGoogle Scholar
- Condic ML, Lemons ML: Extracellular matrix in spinal cord regeneration: getting beyond attraction and inhibition. Neuroreport. 2002, 13: A37-48. 10.1097/00001756-200203040-00002.View ArticlePubMedGoogle Scholar
- McKeon RJ, Hoke A, Silver J: Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol. 1995, 136: 32-43. 10.1006/exnr.1995.1081.View ArticlePubMedGoogle Scholar
- Caubit X, Riou JF, Coulon J, Arsanto JP, Benraiss A, Boucaut JC, Thouveny Y: Tenascin expression in developing, adult and regenerating caudal spinal cord in the urodele amphibians. Int J Dev Biol. 1994, 38: 661-672.PubMedGoogle Scholar
- Larrivee B, Freitas C, Suchting S, Brunet I, Eichmann A: Guidance of vascular development: lessons from the nervous system. Circ Res. 2009, 104: 428-441. 10.1161/CIRCRESAHA.108.188144.View ArticlePubMedGoogle Scholar
- Mey J, D JM, Brook G, Liu RH, Zhang YP, Koopmans G, McCaffery P: Retinoic acid synthesis by a population of NG2-positive cells in the injured spinal cord. Eur J Neurosci. 2005, 21: 1555-1568. 10.1111/j.1460-9568.2005.03928.x.View ArticlePubMedGoogle Scholar
- Li Y, Field PM, Raisman G: Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci. 1998, 18: 10514-10524.PubMedGoogle Scholar
- Lakatos A, Smith PM, Barnett SC, Franklin RJ: Meningeal cells enhance limited CNS remyelination by transplanted olfactory ensheathing cells. Brain. 2003, 126: 598-609. 10.1093/brain/awg055.View ArticlePubMedGoogle Scholar
- Harty M, Neff AW, King MW, Mescher AL: Regeneration or scarring: an immunologic perspective. Dev Dyn. 2003, 226: 268-279. 10.1002/dvdy.10239.View ArticlePubMedGoogle Scholar
- Fitch MT, Doller C, Combs CK, Landreth GE, Silver J: Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci. 1999, 19: 8182-8198.PubMedGoogle Scholar
- Horn KP, Busch SA, Hawthorne AL, van Rooijen N, Silver J: Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J Neurosci. 2008, 28: 9330-9341. 10.1523/JNEUROSCI.2488-08.2008.PubMed CentralView ArticlePubMedGoogle Scholar
- Donnelly DJ, Popovich PG: Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008, 209: 378-388. 10.1016/j.expneurol.2007.06.009.PubMed CentralView ArticlePubMedGoogle Scholar
- Simpson SB: Fasciculation and guidance of regenerating central axons by the ependyma. Spinal Cord Reconstruction. Edited by: Kao CC, Bunge RP, Reier PJ. 1983, New York: Raven Press, 151-162.Google Scholar
- Schonbach C: The neuroglia in the spinal cord of the newt, Triturus viridescens. J Comp Neurol. 1969, 135: 93-120. 10.1002/cne.901350107.View ArticlePubMedGoogle Scholar
- Ghashghaei HT, Lai C, Anton ES: Neuronal migration in the adult brain: are we there yet?. Nat Rev Neurosci. 2007, 8: 141-151. 10.1038/nrn2074.View ArticlePubMedGoogle Scholar
- Ferguson MW, O'Kane S: Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci. 2004, 359: 839-850. 10.1098/rstb.2004.1475.PubMed CentralView ArticlePubMedGoogle Scholar
- Borrell V, Marin O: Meninges control tangential migration of hem-derived Cajal-Retzius cells via CXCL12/CXCR4 signaling. Nat Neurosci. 2006, 9: 1284-1293. 10.1038/nn1764.View ArticlePubMedGoogle Scholar
- Siegenthaler JA, Ashique AM, Zarbalis K, Patterson KP, Hecht JH, Kane MA, Folias AE, Choe Y, May SR, Kume T, Napoli JL, Peterson AS, Pleasure SJ: Retinoic acid from the meninges regulates cortical neuron generation. Cell. 2009, 139: 597-609. 10.1016/j.cell.2009.10.004.PubMed CentralView ArticlePubMedGoogle Scholar
- Shearer MC, Niclou SP, Brown D, Asher RA, Holtmaat AJ, Levine JM, Verhaagen J, Fawcett JW: The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathways. Mol Cell Neurosci. 2003, 24: 913-925. 10.1016/j.mcn.2003.09.004.View ArticlePubMedGoogle Scholar
- Clagett-Dame M, McNeill EM, Muley PD: Role of all-trans retinoic acid in neurite outgrowth and axonal elongation. J Neurobiol. 2006, 66: 739-756. 10.1002/neu.20241.View ArticlePubMedGoogle Scholar
- Wang G, Scott SA: Retinoid signaling is involved in governing the waiting period for axons in chick hindlimb. Dev Biol. 2008, 321: 216-226. 10.1016/j.ydbio.2008.06.021.PubMed CentralView ArticlePubMedGoogle Scholar
- Becker CG, Becker T, Meyer RL, Schachner M: Tenascin-R inhibits the growth of optic fibers in vitro but is rapidly eliminated during nerve regeneration in the salamander Pleurodeles waltl. J Neurosci. 1999, 19: 813-827.PubMedGoogle Scholar
- Condic ML, Snow DM, Letourneau PC: Embryonic neurons adapt to the inhibitory proteoglycan aggercan by increasing integrin expression. J Neurosci. 1999, 19: 10036-10043.PubMedGoogle Scholar
- Lemons ML, Barua S, Abanto ML, Halfter W, Condic ML: Adaptation of sensory neurons to hyalectin and decorin proteoglycans. J Neurosci. 2005, 25: 4964-4973. 10.1523/JNEUROSCI.0773-05.2005.View ArticlePubMedGoogle Scholar
- Kumar A, Godwin JW, Gates PB, Garza-Garcia AA, Brockes JP: Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science. 2007, 318: 772-777. 10.1126/science.1147710.PubMed CentralView ArticlePubMedGoogle Scholar
- Tennant M, Beazley LD: A breakdown of the blood-brain barrier is associated with optic nerve regeneration in the frog. Vis Neurosci. 1992, 9: 149-155. 10.1017/S0952523800009615.View ArticlePubMedGoogle Scholar
- Reier PJ, Stensaas LJ, Guth L: The astrocytic scar as an impediment to regeneration in the central nervous system. Spinal Cord Reconstruction. Edited by: Kao CC, Bunge RP, Reier PJ. 1983, New York: Raven Press, 163-196.Google Scholar
- Ferretti P, Zhang F, O'Neill P: Changes in spinal cord regenerative ability through phylogenesis and development: lessons to be learnt. Dev Dyn. 2003, 226: 245-256. 10.1002/dvdy.10226.View ArticlePubMedGoogle Scholar
- Odelberg SJ: Cellular plasticity in vertebrate regeneration. Anat Rec B New Anat. 2005, 287: 25-35.View ArticlePubMedGoogle Scholar
- Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I, Tedeschi A, Park KK, Jin D, Cai B, Xu B, Connolly L, Steward O, Zheng B, He Z: PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci. 2010, 13: 1075-1081. 10.1038/nn.2603.PubMed CentralView ArticlePubMedGoogle Scholar
- McLean IW, Nakane PK: Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem. 1974, 22: 1077-1083.View ArticlePubMedGoogle Scholar
- Kardon G: Muscle and tendon morphogenesis in the avian hind limb. Development. 1998, 125: 4019-4032.PubMedGoogle Scholar
- Klymkowsky MW, Hanken J: Whole-mount staining of Xenopus and other vertebrates. Methods in Cell Biology. 1991, Academic Press, Inc, 36: 419-441. full_text.Google Scholar
- Zukor KA, Kent DT, Odelberg SJ: Fluorescent whole-mount method for visualizing 3-dimensional relationships in intact and regenerating adult newt spinal cords. Dev Dyn.
- Tokuyasu KT: Use of poly(vinylpyrrolidone) and poly(vinyl alcohol) for cryoultramicrotomy. Histochem J. 1989, 21: 163-171. 10.1007/BF01007491.View ArticlePubMedGoogle Scholar
- Wei Y, Yang EV, Klatt KP, Tassava RA: Monoclonal antibody MT2 identifies the urodele alpha 1 chain of type XII collagen, a developmentally regulated extracellular matrix protein in regenerating newt limbs. Dev Biol. 1995, 168: 503-513. 10.1006/dbio.1995.1098.View ArticlePubMedGoogle Scholar
- Onda H, Goldhamer DJ, Tassava RA: An extracellular matrix molecule of newt and axolotl regenerating limb blastemas and embryonic limb buds: immunological relationship of MT1 antigen with tenascin. Development. 1990, 108: 657-668.PubMedGoogle Scholar
- Nace JD, Tassava RA: Examination of fibronectin distribution and its sources in the regenerating newt limb by immunocytochemistry and in situ hybridization. Dev Dyn. 1995, 202: 153-164.View ArticlePubMedGoogle Scholar
- Bader HL, Keene DR, Charvet B, Veit G, Driever W, Koch M, Ruggiero F: Zebrafish collagen XII is present in embryonic connective tissue sheaths (fascia) and basement membranes. Matrix Biol. 2009, 28: 32-43. 10.1016/j.matbio.2008.09.580.View ArticlePubMedGoogle Scholar
- Reichenberger E, Baur S, Sukotjo C, Olsen BR, Karimbux NY, Nishimura I: Collagen XII mutation disrupts matrix structure of periodontal ligament and skin. J Dent Res. 2000, 79: 1962-1968. 10.1177/00220345000790120701.View ArticlePubMedGoogle Scholar
- ImageJ. [http://rsb.info.nih.gov/ij/]
- Anderson JR, Jones BW, Yang JH, Shaw MV, Watt CB, Koshevoy P, Spaltenstein J, Jurrus EUVK, Whitaker RT, Mastronarde D, Tasdizen T, Marc RE: A computational framework for ultrastructural mapping of neural circuitry. PLoS Biol. 2009, 7: e1000074-10.1371/journal.pbio.1000074.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.